Exact Sciences
EXAS
$66.85
Share price
-3.85%
Change (1 day)
40.47%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Exact Sciences (EXAS) - Total assets
Total assets on the balance sheet as of June 2023 : $6.35 B
According to Exact Sciences's latest financial reports the company's total assets are $6.35 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Exact Sciences - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $6.22 B | -6.85% |
| 2021-12-31 | $6.68 B | 35.73% |
| 2020-12-31 | $4.92 B | 40.49% |
| 2019-12-31 | $3.50 B | 130.03% |
| 2018-12-31 | $1.52 B | 154.61% |
| 2017-12-31 | $0.59 B | 58.75% |
| 2016-12-31 | $0.37 B | 3.5% |
| 2015-12-31 | $0.36 B | 16.9% |
| 2014-12-31 | $0.31 B | 112.53% |
| 2013-12-31 | $0.14 B | 30.78% |
| 2012-12-31 | $0.11 B | 15.64% |
| 2011-12-31 | $96.95 M | 0.45% |
| 2010-12-31 | $96.51 M | 274.52% |
| 2009-12-31 | $25.77 M | 336.93% |
| 2008-12-31 | $5.89 M | -59.59% |
| 2007-12-31 | $14.59 M | -38.85% |
| 2006-12-31 | $23.86 M | -36.93% |
| 2005-12-31 | $37.84 M | -32.55% |
| 2004-12-31 | $56.11 M | 61.79% |
| 2003-12-31 | $34.68 M | -30.76% |
| 2002-12-31 | $50.08 M | -20.62% |
| 2001-12-31 | $63.1 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $136.23 B | 2,043.54% | 🇫🇷 France |
 Veracyte VCYT | $1.16 B | -81.73% | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | N/A | 🇺🇸 USA |
 Myriad Genetics MYGN | $1.18 B | -81.32% | 🇺🇸 USA |
 Biocept
BIOC | $22.1 M | -99.65% | 🇺🇸 USA |